<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01299480</url>
  </required_header>
  <id_info>
    <org_study_id>B1971012</org_study_id>
    <secondary_id>6108A1-2003</secondary_id>
    <secondary_id>2009-014493-18</secondary_id>
    <nct_id>NCT01299480</nct_id>
  </id_info>
  <brief_title>A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To &lt;19 Years</brief_title>
  <official_title>A Phase 2, Randomized, Placebo-controlled, Single-blind Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-dose Regimens In Healthy Subjects Aged ≥11 To &lt;19 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to look at a new vaccine that might prevent meningococcal disease, and to look
      at the safety of the new vaccine as well as how well it is tolerated. This study will also
      look at this vaccine being given 2 or 3 times. This study will be done in healthy
      adolescents.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Greater Than or Equal to (&gt;=) Lower Limit of Quantitation: Group 1 and 2 Participants</measure>
    <time_frame>1 month after Injection 4</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Reporting At Least 1 Adverse Event (AE)</measure>
    <time_frame>Injection 1 up to 1 month after Injection 4</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ: Group 3 Participants</measure>
    <time_frame>1 month after Injection 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Bactericidal Assay Using Human Complement (hSBA) Geometric Mean Titers (GMTs)</measure>
    <time_frame>Before Injection (Inj) 1, 1 Month (M) after (aft) Injection 2, 3, 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ</measure>
    <time_frame>Before Injection 1, 1 Month after Injection 2, 3, 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Serum Bactericidal Assay Using Human Complement (hSBA) Titer &gt;= Prespecified Titer Level</measure>
    <time_frame>Before Injection 1, 1 Month after Injection 2, 3, 4</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage of Participants Achieving At Least 4-fold Increase in hSBA Titer</measure>
    <time_frame>1 month after Injection 2, 3, 4</time_frame>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">1714</enrollment>
  <condition>Meningococcal Vaccine</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rLP2086 vaccine at visits 1, 2 and 5, saline at visit 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rLP2086 vaccine at visits 1, 3, and 5, saline at visit 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rLP2086 vaccine at visits 1, and 5, saline at visits 2 and 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rLP2086 at visits 1 and 3, saline at visits 2 and 5</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rLP2086 at visits 3 and 5, saline at visits 1 and 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccine</intervention_name>
    <description>rLP2086 vaccine at visits 1, 2 and 5, saline at visit 3</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>Group 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccine</intervention_name>
    <description>rLP2086 vaccine at visits 1, 3, and 5, saline at visit 2</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Group 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccine</intervention_name>
    <description>rLP2086 vaccine at visits 1, and 5, saline at visits 2 and 3</description>
    <arm_group_label>Group 3</arm_group_label>
    <other_name>Group 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccine</intervention_name>
    <description>rLP2086 at visits 1 and 3, saline at visits 2 and 5</description>
    <arm_group_label>Group 4</arm_group_label>
    <other_name>Group 4</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Vaccine</intervention_name>
    <description>rLP2086 at visits 3 and 5, saline at visits 1 and 2</description>
    <arm_group_label>Group 5</arm_group_label>
    <other_name>Group 5</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Evidence of a personally signed and dated informed consent document indicating that
             the parent/legally acceptable representative and/or subject has been informed of all
             pertinent aspects of the study.

          -  Parent/legally acceptable representative and/or subjects who are willing and able to
             comply with scheduled visits, treatment plan, laboratory tests, and other study
             procedures.

          -  Male or female subject aged ≥11 and &lt;19 years at the time of enrollment.

          -  Available for the entire study period and can be reached by telephone.

          -  Healthy subject as determined by medical history, physical examination, and judgment
             of the investigator.

          -  All male and female subjects must agree to practice a form of effective contraception,
             such as barrier contraception (ie, condom plus spermicide, a female condom, diaphragm,
             cervical cap or intrauterine device), implants, injectables, combined oral
             contraceptives or sexual abstinence prior to entering into the study, for the duration
             of the vaccination period and for 28 days after the last study vaccination.For
             Germany: The phrase sexual abstinence is not applicable, with the understanding that
             all male and all female subjects of childbearing potential must practice an effective
             form of contraception during the study.

          -  Negative urine pregnancy test for female subjects.

        Exclusion Criteria:

          -  Previous vaccination with any meningococcal serogroup B vaccine.

          -  A previous anaphylactic reaction to any vaccine or vaccine-related component.

          -  Bleeding diathesis or condition associated with prolonged bleeding time that would
             contraindicate intramuscular injection.

          -  A known or suspected disease of the immune system or those receiving immunosuppressive
             therapy.

          -  History of culture-proven disease caused by Neisseria meningitidis or Neisseria
             gonorrhoeae.

          -  Significant neurological disorder or history of seizure (excluding simple febrile
             seizure).

          -  Receipt of any blood products, including immunoglobulin within 6 months before the
             first study vaccination.

          -  Current chronic use of systemic antibiotics.

          -  Participation in other studies during study participation. Participation in purely
             observational studies is acceptable.

          -  Received any investigational drugs, vaccines or devices within 28 days before
             administration of the first study vaccination.

          -  Any neuroinflammatory or autoimmune condition, including, but not limited to,
             transverse myelitis, uveitis, optic neuritis, and multiple sclerosis.

          -  Other severe acute or chronic medical or psychiatric condition or laboratory
             abnormality that may increase the risk associated with study participation or
             investigational product administration or may interfere with the interpretation of
             study results and, in the judgment of the investigator, would make the subject
             inappropriate for entry into this study.

          -  Subjects who are investigational site staff members or subjects who are Pfizer
             employees directly involved in the conduct of the trial.

          -  Subject is pregnant or breastfeeding.

          -  Subject is a direct descendant of study site or Pfizer personnel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Brandys nad Labem - Stara Boleslav</city>
        <zip>25001</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Chlumec nad Cidlinou</city>
        <zip>50351</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Holice</city>
        <zip>53401</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50002</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50004</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Jindrichuv Hradec</city>
        <zip>37701</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Odolena Voda</city>
        <zip>25070</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Pardubice</city>
        <zip>53002</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Pardubice</city>
        <zip>53012</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Praha - Horni Pocernice</city>
        <zip>19300</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Praha - Nusle</city>
        <zip>14000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Praha 1</city>
        <zip>11000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Praha 6 - Petriny</city>
        <zip>16200</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Praha 6</city>
        <zip>16000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordinace praktickeho lekare pro deti a dorost</name>
      <address>
        <city>Sezemice</city>
        <zip>53304</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Infektionsmedicinsk Afdeling Q</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki South Vaccine Research Clinic</name>
      <address>
        <city>Helsinki</city>
        <zip>00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki East Vaccine Research Clinic</name>
      <address>
        <city>Helsinki</city>
        <zip>00930</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki East Vaccine Research Clinic</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Järvenpää Vaccine Research Clinic</name>
      <address>
        <city>Järvenpää</city>
        <zip>04400</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kokkola Vaccine Research Centre</name>
      <address>
        <city>Kokkola</city>
        <zip>67100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahti Vaccine Research Clinic</name>
      <address>
        <city>Lahti</city>
        <zip>15140</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu Vaccine Research Clinic</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Espoo Vaccine Reserach Clinic</name>
      <address>
        <city>Piispansilta 11</city>
        <zip>02230</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pori Vaccine Research Clinic</name>
      <address>
        <city>Pori</city>
        <zip>28100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seinäjoki Vaccine Research Clinic</name>
      <address>
        <city>Seinäjoki</city>
        <zip>60100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere Vaccine Research Clinic</name>
      <address>
        <city>Tampere</city>
        <zip>33100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku Vaccine Research Clinic</name>
      <address>
        <city>Turku</city>
        <zip>20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vantaa East Vaccine Research Clinic</name>
      <address>
        <city>Vantaa</city>
        <zip>01300</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arztpraxis</name>
      <address>
        <city>Bad Saulgau</city>
        <zip>88348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderarzt-Praxis</name>
      <address>
        <city>Bramsche</city>
        <zip>49565</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arztpraxis</name>
      <address>
        <city>Kleve</city>
        <zip>47533</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arztpraxis</name>
      <address>
        <city>Neumuenster</city>
        <zip>24534</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderarztpraxis</name>
      <address>
        <city>Neumuenster</city>
        <zip>24534</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderarztpraxis</name>
      <address>
        <city>Neustadt/Aisch</city>
        <zip>91413</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gabinet Lekarski</name>
      <address>
        <city>Debica</city>
        <zip>39-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krakowski Szpital Specjalistyczny, im. Jana Pawla II</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ &quot;Hipokrates-II&quot; Sp. z o.o.</name>
      <address>
        <city>Krakow</city>
        <zip>31-223</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Salmed</name>
      <address>
        <city>Leczna</city>
        <zip>21-010</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nzoz &quot;Anamed&quot; S.C</name>
      <address>
        <city>Lubartow</city>
        <zip>21-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Praktyka Lekarza Rodzinnego Eskulap</name>
      <address>
        <city>Lublin</city>
        <zip>20-044</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Praktyka Lekarza Rodzinnego Alina Grocka-Wlazlak</name>
      <address>
        <city>Oborniki Slaskie</city>
        <zip>55-120</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny ZOZ nad Matka i Dzieckiem,</name>
      <address>
        <city>Poznan</city>
        <zip>61709</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZLA Michalkowice Jarosz i Partnerzy</name>
      <address>
        <city>Siemianowice Slaskie</city>
        <zip>41-103</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Nasz Lekarz</name>
      <address>
        <city>Torun</city>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital im. Sw. Jadwigi Slaskiej, Oddzial Pediatryczny</name>
      <address>
        <city>Trzebnica</city>
        <zip>55-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General de Catalunya</name>
      <address>
        <city>Sant Cugat Del Valles</city>
        <state>Barcelona</state>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cap Vila Vella</name>
      <address>
        <city>Sant Vicenç Del Horts</city>
        <state>Barcelona</state>
        <zip>08620</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Pediatric Mares-Riera</name>
      <address>
        <city>Blanes</city>
        <state>Girona</state>
        <zip>17300</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud de Paiporta</name>
      <address>
        <city>Paiporta</city>
        <state>Valencia</state>
        <zip>46200</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Quart de Poblet</name>
      <address>
        <city>Quart de Poblet</city>
        <state>Valencia</state>
        <zip>46930</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen Del Mar</name>
      <address>
        <city>Almeria</city>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cap Roquetes-Canteres</name>
      <address>
        <city>Barcelona</city>
        <zip>08042</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Malvarrosa</name>
      <address>
        <city>Valencia</city>
        <zip>46011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Superior de Salud Publica</name>
      <address>
        <city>Valencia</city>
        <zip>46020</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Republica Argentina</name>
      <address>
        <city>Valencia</city>
        <zip>46021</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Salud Trafalgar</name>
      <address>
        <city>Valencia</city>
        <zip>46023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malarsjukhuset, Infektionsmottagningen</name>
      <address>
        <city>Eskilstuna</city>
        <zip>631 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Skanes Universitetssjukhus Malmo, Barn- och Ungdomscentrum</name>
      <address>
        <city>Malmo</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CRS, Clinical Research Support</name>
      <address>
        <city>Orebro</city>
        <zip>703 62</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1971012&amp;StudyName=A%20Trial%20To%20Assess%20The%20Safety%2C%20Tolerability%2C%20And%20Immunogenicity%20Of%20Rlp2086%20Vaccine%20When%20Administered%20In%20Either%202-%20Or%203-Dose%20Regimens</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2011</study_first_submitted>
  <study_first_submitted_qc>February 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2011</study_first_posted>
  <results_first_submitted>November 21, 2014</results_first_submitted>
  <results_first_submitted_qc>June 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 4, 2015</results_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy adolescents</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>A total of 1714 participants were enrolled in this study. Of these, 1 participant was not randomized but was vaccinated with Saline at Injection 1. This participant was included in safety population and not intent-to-treat population. Participant Flow includes only randomized intent to treat participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
        </group>
        <group group_id="P2">
          <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
        </group>
        <group group_id="P3">
          <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
        </group>
        <group group_id="P4">
          <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
        </group>
        <group group_id="P5">
          <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
          <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="427"/>
                <participants group_id="P2" count="430"/>
                <participants group_id="P3" count="427"/>
                <participants group_id="P4" count="286"/>
                <participants group_id="P5" count="143"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="385"/>
                <participants group_id="P2" count="395"/>
                <participants group_id="P3" count="386"/>
                <participants group_id="P4" count="261"/>
                <participants group_id="P5" count="123"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="41"/>
                <participants group_id="P4" count="25"/>
                <participants group_id="P5" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No longer willing to participate</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="13"/>
                <participants group_id="P5" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal due to pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Started, but not vaccinated</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
        </group>
        <group group_id="B2">
          <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
        </group>
        <group group_id="B3">
          <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
        </group>
        <group group_id="B4">
          <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
        </group>
        <group group_id="B5">
          <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
          <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="427"/>
            <count group_id="B2" value="430"/>
            <count group_id="B3" value="427"/>
            <count group_id="B4" value="286"/>
            <count group_id="B5" value="143"/>
            <count group_id="B6" value="1713"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>11- less than (&lt;) 14 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="156"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="156"/>
                    <measurement group_id="B4" value="106"/>
                    <measurement group_id="B5" value="53"/>
                    <measurement group_id="B6" value="629"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 - &lt;19 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="271"/>
                    <measurement group_id="B2" value="272"/>
                    <measurement group_id="B3" value="271"/>
                    <measurement group_id="B4" value="180"/>
                    <measurement group_id="B5" value="90"/>
                    <measurement group_id="B6" value="1084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="212"/>
                    <measurement group_id="B2" value="225"/>
                    <measurement group_id="B3" value="216"/>
                    <measurement group_id="B4" value="139"/>
                    <measurement group_id="B5" value="79"/>
                    <measurement group_id="B6" value="871"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="215"/>
                    <measurement group_id="B2" value="205"/>
                    <measurement group_id="B3" value="211"/>
                    <measurement group_id="B4" value="147"/>
                    <measurement group_id="B5" value="64"/>
                    <measurement group_id="B6" value="842"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Greater Than or Equal to (&gt;=) Lower Limit of Quantitation: Group 1 and 2 Participants</title>
        <time_frame>1 month after Injection 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Greater Than or Equal to (&gt;=) Lower Limit of Quantitation: Group 1 and 2 Participants</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="365"/>
                <count group_id="O2" value="360"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PMB80 [A22] 1:8 (N=360, 357)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.7"/>
                    <measurement group_id="O2" value="95.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2001 [A56] 1:8 (N=362, 359)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.4"/>
                    <measurement group_id="O2" value="98.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2948 [B24] 1:8 (N=354, 354)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.0"/>
                    <measurement group_id="O2" value="88.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2707 [B44] 1:8 (N356, 352)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.5"/>
                    <measurement group_id="O2" value="86.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB80 [A22]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2001 [A56]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2948 [B24]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2707 [B44]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PMB80 [A22]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PMB2001 [A56]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PMB2948 [B24]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>PMB2707 [B44]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Reporting At Least 1 Adverse Event (AE)</title>
        <time_frame>Injection 1 up to 1 month after Injection 4</time_frame>
        <population>Some participants randomized to receive vaccination as per Groups 1, 2 or 4 schedules actually received vaccination as per Group 3 schedule. One participant was not randomized but received Saline at Injection 1 and was included in Group 5. Participants have been presented as per actual administration schedule received.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
          <group group_id="O3">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
            <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting At Least 1 Adverse Event (AE)</title>
          <population>Some participants randomized to receive vaccination as per Groups 1, 2 or 4 schedules actually received vaccination as per Group 3 schedule. One participant was not randomized but received Saline at Injection 1 and was included in Group 5. Participants have been presented as per actual administration schedule received.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="426"/>
                <count group_id="O2" value="414"/>
                <count group_id="O3" value="451"/>
                <count group_id="O4" value="277"/>
                <count group_id="O5" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.9"/>
                    <measurement group_id="O2" value="35.7"/>
                    <measurement group_id="O3" value="35.5"/>
                    <measurement group_id="O4" value="35.7"/>
                    <measurement group_id="O5" value="37.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ: Group 3 Participants</title>
        <time_frame>1 month after Injection 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ: Group 3 Participants</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="371"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PMB80 [A22] 1:8 (N=369)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2001 [A56] 1: 8 (N=370)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2948 [B24] 1:8 (N=359)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PMB2707 [B44] 1:8 (N=356)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB80 [A22]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2001 [A56]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2948 [B24]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>PMB2707 [B44]: Response rate was compared with 50%, using 1-sided exact test based on binomial distribution. p-Value &lt;0.0125 was considered significant.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Binomial Distribution</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Bactericidal Assay Using Human Complement (hSBA) Geometric Mean Titers (GMTs)</title>
        <time_frame>Before Injection (Inj) 1, 1 Month (M) after (aft) Injection 2, 3, 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
          <group group_id="O3">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
            <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Bactericidal Assay Using Human Complement (hSBA) Geometric Mean Titers (GMTs)</title>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="365"/>
                <count group_id="O2" value="360"/>
                <count group_id="O3" value="371"/>
                <count group_id="O4" value="241"/>
                <count group_id="O5" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Inj1: PMB80 [A22]; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" lower_limit="6.41" upper_limit="7.87"/>
                    <measurement group_id="O2" value="6.3" lower_limit="5.72" upper_limit="6.95"/>
                    <measurement group_id="O3" value="6.4" lower_limit="5.84" upper_limit="7.02"/>
                    <measurement group_id="O4" value="6.4" lower_limit="5.66" upper_limit="7.22"/>
                    <measurement group_id="O5" value="6.8" lower_limit="5.59" upper_limit="8.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2: PMB80 [A22]; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.4" lower_limit="21.25" upper_limit="27.94"/>
                    <measurement group_id="O2" value="10.7" lower_limit="9.44" upper_limit="12.09"/>
                    <measurement group_id="O3" value="12.0" lower_limit="10.58" upper_limit="13.60"/>
                    <measurement group_id="O4" value="13.3" lower_limit="11.21" upper_limit="15.76"/>
                    <measurement group_id="O5" value="7.1" lower_limit="5.86" upper_limit="8.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3: PMB80 [A22]; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7" lower_limit="15.28" upper_limit="20.47"/>
                    <measurement group_id="O2" value="32.9" lower_limit="29.34" upper_limit="36.92"/>
                    <measurement group_id="O3" value="10.3" lower_limit="9.09" upper_limit="11.68"/>
                    <measurement group_id="O4" value="37.1" lower_limit="32.23" upper_limit="42.76"/>
                    <measurement group_id="O5" value="16.0" lower_limit="12.15" upper_limit="21.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4: PMB80 [A22]; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.1" lower_limit="48.87" upper_limit="62.07"/>
                    <measurement group_id="O2" value="56.3" lower_limit="50.91" upper_limit="62.27"/>
                    <measurement group_id="O3" value="48.4" lower_limit="43.45" upper_limit="53.86"/>
                    <measurement group_id="O4" value="14.2" lower_limit="12.08" upper_limit="16.73"/>
                    <measurement group_id="O5" value="39.6" lower_limit="32.31" upper_limit="48.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1: PMB2001 [A56]; N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" lower_limit="6.06" upper_limit="7.64"/>
                    <measurement group_id="O2" value="6.1" lower_limit="5.54" upper_limit="6.77"/>
                    <measurement group_id="O3" value="6.7" lower_limit="6.00" upper_limit="7.48"/>
                    <measurement group_id="O4" value="6.3" lower_limit="5.54" upper_limit="7.15"/>
                    <measurement group_id="O5" value="6.2" lower_limit="5.10" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2: PMB2001 [A56]; N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.3" lower_limit="68.54" upper_limit="87.12"/>
                    <measurement group_id="O2" value="17.0" lower_limit="14.56" upper_limit="19.96"/>
                    <measurement group_id="O3" value="18.5" lower_limit="15.81" upper_limit="21.63"/>
                    <measurement group_id="O4" value="17.7" lower_limit="14.45" upper_limit="21.58"/>
                    <measurement group_id="O5" value="6.8" lower_limit="5.52" upper_limit="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3: PMB2001 [A56]; N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.3" lower_limit="41.96" upper_limit="55.50"/>
                    <measurement group_id="O2" value="94.6" lower_limit="84.64" upper_limit="105.68"/>
                    <measurement group_id="O3" value="15.1" lower_limit="12.89" upper_limit="17.74"/>
                    <measurement group_id="O4" value="104.9" lower_limit="93.16" upper_limit="118.05"/>
                    <measurement group_id="O5" value="26.8" lower_limit="19.48" upper_limit="36.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4: PMB2001 [A56]; N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152.9" lower_limit="137.23" upper_limit="170.47"/>
                    <measurement group_id="O2" value="155.6" lower_limit="140.39" upper_limit="172.38"/>
                    <measurement group_id="O3" value="125.6" lower_limit="112.59" upper_limit="140.17"/>
                    <measurement group_id="O4" value="26.5" lower_limit="22.24" upper_limit="31.58"/>
                    <measurement group_id="O5" value="111.8" lower_limit="92.73" upper_limit="134.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1: PMB2948 [B24]; N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" lower_limit="4.93" upper_limit="5.75"/>
                    <measurement group_id="O2" value="5.1" lower_limit="4.77" upper_limit="5.52"/>
                    <measurement group_id="O3" value="5.0" lower_limit="4.70" upper_limit="5.38"/>
                    <measurement group_id="O4" value="4.9" lower_limit="4.49" upper_limit="5.24"/>
                    <measurement group_id="O5" value="5.1" lower_limit="4.51" upper_limit="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2: PMB2948 [B24]; N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" lower_limit="12.15" upper_limit="15.57"/>
                    <measurement group_id="O2" value="8.2" lower_limit="7.38" upper_limit="9.21"/>
                    <measurement group_id="O3" value="9.2" lower_limit="8.20" upper_limit="10.28"/>
                    <measurement group_id="O4" value="9.8" lower_limit="8.39" upper_limit="11.35"/>
                    <measurement group_id="O5" value="5.3" lower_limit="4.70" upper_limit="6.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3: PMB2948 [B24]; N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" lower_limit="9.61" upper_limit="12.50"/>
                    <measurement group_id="O2" value="14.9" lower_limit="13.20" upper_limit="16.73"/>
                    <measurement group_id="O3" value="7.5" lower_limit="6.75" upper_limit="8.35"/>
                    <measurement group_id="O4" value="17.7" lower_limit="15.24" upper_limit="20.49"/>
                    <measurement group_id="O5" value="12.6" lower_limit="10.01" upper_limit="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4: PMB2948 [B24]; N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.1" lower_limit="25.88" upper_limit="32.66"/>
                    <measurement group_id="O2" value="25.6" lower_limit="23.03" upper_limit="28.45"/>
                    <measurement group_id="O3" value="20.6" lower_limit="18.38" upper_limit="23.18"/>
                    <measurement group_id="O4" value="8.0" lower_limit="7.01" upper_limit="9.24"/>
                    <measurement group_id="O5" value="14.7" lower_limit="12.01" upper_limit="18.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1: PMB2707 [B44]; N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" lower_limit="4.18" upper_limit="4.54"/>
                    <measurement group_id="O2" value="4.5" lower_limit="4.24" upper_limit="4.67"/>
                    <measurement group_id="O3" value="4.5" lower_limit="4.26" upper_limit="4.70"/>
                    <measurement group_id="O4" value="4.6" lower_limit="4.28" upper_limit="4.90"/>
                    <measurement group_id="O5" value="4.4" lower_limit="4.04" upper_limit="4.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2: PMB2707 [B44]; N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" lower_limit="11.29" upper_limit="15.11"/>
                    <measurement group_id="O2" value="5.5" lower_limit="5.04" upper_limit="6.01"/>
                    <measurement group_id="O3" value="5.7" lower_limit="5.19" upper_limit="6.30"/>
                    <measurement group_id="O4" value="5.9" lower_limit="5.19" upper_limit="6.74"/>
                    <measurement group_id="O5" value="4.4" lower_limit="4.04" upper_limit="4.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3: PMB2707 [B44]; N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" lower_limit="7.40" upper_limit="9.60"/>
                    <measurement group_id="O2" value="15.5" lower_limit="13.51" upper_limit="17.87"/>
                    <measurement group_id="O3" value="5.2" lower_limit="4.78" upper_limit="5.68"/>
                    <measurement group_id="O4" value="19.1" lower_limit="16.03" upper_limit="22.78"/>
                    <measurement group_id="O5" value="6.8" lower_limit="5.45" upper_limit="8.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4: PMB2707 [B44]; N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.3" lower_limit="35.16" upper_limit="46.11"/>
                    <measurement group_id="O2" value="35.0" lower_limit="30.63" upper_limit="39.91"/>
                    <measurement group_id="O3" value="22.5" lower_limit="19.60" upper_limit="25.72"/>
                    <measurement group_id="O4" value="6.2" lower_limit="5.52" upper_limit="7.07"/>
                    <measurement group_id="O5" value="17.8" lower_limit="14.12" upper_limit="22.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ</title>
        <time_frame>Before Injection 1, 1 Month after Injection 2, 3, 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
          <group group_id="O3">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
            <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving hSBA Titer &gt;=LLOQ</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="365"/>
                <count group_id="O2" value="360"/>
                <count group_id="O3" value="371"/>
                <count group_id="O4" value="241"/>
                <count group_id="O5" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Inj1: PMB80[A22] 1:8; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.1" lower_limit="6.41" upper_limit="7.87"/>
                    <measurement group_id="O2" value="21.9" lower_limit="5.72" upper_limit="6.95"/>
                    <measurement group_id="O3" value="24.7" lower_limit="5.84" upper_limit="7.02"/>
                    <measurement group_id="O4" value="22.6" lower_limit="5.66" upper_limit="7.22"/>
                    <measurement group_id="O5" value="25.0" lower_limit="5.59" upper_limit="8.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22]1:8; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.6" lower_limit="21.25" upper_limit="27.94"/>
                    <measurement group_id="O2" value="46.7" lower_limit="9.44" upper_limit="12.09"/>
                    <measurement group_id="O3" value="51.3" lower_limit="10.58" upper_limit="13.60"/>
                    <measurement group_id="O4" value="52.2" lower_limit="11.21" upper_limit="15.76"/>
                    <measurement group_id="O5" value="28.2" lower_limit="5.86" upper_limit="8.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22]1:8; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.0" lower_limit="15.28" upper_limit="20.47"/>
                    <measurement group_id="O2" value="88.7" lower_limit="29.34" upper_limit="36.92"/>
                    <measurement group_id="O3" value="44.7" lower_limit="9.09" upper_limit="11.68"/>
                    <measurement group_id="O4" value="90.8" lower_limit="32.23" upper_limit="42.76"/>
                    <measurement group_id="O5" value="55.9" lower_limit="12.15" upper_limit="21.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22]1:8; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.7" lower_limit="48.87" upper_limit="62.07"/>
                    <measurement group_id="O2" value="95.0" lower_limit="50.91" upper_limit="62.27"/>
                    <measurement group_id="O3" value="93.5" lower_limit="43.45" upper_limit="53.86"/>
                    <measurement group_id="O4" value="57.7" lower_limit="12.08" upper_limit="16.73"/>
                    <measurement group_id="O5" value="91.9" lower_limit="32.31" upper_limit="48.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2001[A56]1:8; N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.9" lower_limit="6.06" upper_limit="7.64"/>
                    <measurement group_id="O2" value="18.7" lower_limit="5.54" upper_limit="6.77"/>
                    <measurement group_id="O3" value="21.7" lower_limit="6.00" upper_limit="7.48"/>
                    <measurement group_id="O4" value="19.0" lower_limit="5.54" upper_limit="7.15"/>
                    <measurement group_id="O5" value="17.8" lower_limit="5.10" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001[A56]1:8; N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.6" lower_limit="68.54" upper_limit="87.12"/>
                    <measurement group_id="O2" value="56.2" lower_limit="14.56" upper_limit="19.96"/>
                    <measurement group_id="O3" value="58.8" lower_limit="15.81" upper_limit="21.63"/>
                    <measurement group_id="O4" value="56.0" lower_limit="14.45" upper_limit="21.58"/>
                    <measurement group_id="O5" value="22.5" lower_limit="5.52" upper_limit="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3;PMB2001[A56]1:8; N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.1" lower_limit="41.96" upper_limit="55.50"/>
                    <measurement group_id="O2" value="97.9" lower_limit="84.64" upper_limit="105.68"/>
                    <measurement group_id="O3" value="50.6" lower_limit="12.89" upper_limit="17.74"/>
                    <measurement group_id="O4" value="100.0" lower_limit="93.16" upper_limit="118.05"/>
                    <measurement group_id="O5" value="67.6" lower_limit="19.48" upper_limit="36.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001[A56]1:8; N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.4" lower_limit="137.23" upper_limit="170.47"/>
                    <measurement group_id="O2" value="98.9" lower_limit="140.39" upper_limit="172.38"/>
                    <measurement group_id="O3" value="98.4" lower_limit="12.89" upper_limit="17.74"/>
                    <measurement group_id="O4" value="76.8" lower_limit="93.16" upper_limit="118.05"/>
                    <measurement group_id="O5" value="99.1" lower_limit="19.48" upper_limit="36.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948[B24]1:8; N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.3" lower_limit="4.93" upper_limit="5.75"/>
                    <measurement group_id="O2" value="13.8" lower_limit="4.77" upper_limit="5.52"/>
                    <measurement group_id="O3" value="13.0" lower_limit="4.70" upper_limit="5.38"/>
                    <measurement group_id="O4" value="11.2" lower_limit="4.49" upper_limit="5.24"/>
                    <measurement group_id="O5" value="14.3" lower_limit="4.51" upper_limit="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948[B24]1:8; N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.2" lower_limit="12.15" upper_limit="15.57"/>
                    <measurement group_id="O2" value="39.4" lower_limit="7.38" upper_limit="9.21"/>
                    <measurement group_id="O3" value="43.8" lower_limit="8.20" upper_limit="10.28"/>
                    <measurement group_id="O4" value="45.3" lower_limit="8.39" upper_limit="11.35"/>
                    <measurement group_id="O5" value="18.2" lower_limit="4.70" upper_limit="6.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948[B24]1:8; N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.6" lower_limit="9.61" upper_limit="12.50"/>
                    <measurement group_id="O2" value="70.3" lower_limit="13.20" upper_limit="16.73"/>
                    <measurement group_id="O3" value="35.6" lower_limit="6.75" upper_limit="8.35"/>
                    <measurement group_id="O4" value="73.0" lower_limit="15.24" upper_limit="20.49"/>
                    <measurement group_id="O5" value="56.9" lower_limit="10.01" upper_limit="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948[B24]1:8; N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.0" lower_limit="25.88" upper_limit="32.66"/>
                    <measurement group_id="O2" value="88.4" lower_limit="23.03" upper_limit="28.45"/>
                    <measurement group_id="O3" value="81.1" lower_limit="18.38" upper_limit="23.18"/>
                    <measurement group_id="O4" value="35.5" lower_limit="7.01" upper_limit="9.24"/>
                    <measurement group_id="O5" value="69.1" lower_limit="12.01" upper_limit="18.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707[B44]1:8; N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="4.18" upper_limit="4.54"/>
                    <measurement group_id="O2" value="6.2" lower_limit="4.24" upper_limit="4.67"/>
                    <measurement group_id="O3" value="6.2" lower_limit="4.26" upper_limit="4.70"/>
                    <measurement group_id="O4" value="7.5" lower_limit="4.28" upper_limit="4.90"/>
                    <measurement group_id="O5" value="4.4" lower_limit="4.04" upper_limit="4.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707[B44]1:8; N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.0" lower_limit="11.29" upper_limit="15.11"/>
                    <measurement group_id="O2" value="15.7" lower_limit="5.04" upper_limit="6.01"/>
                    <measurement group_id="O3" value="17.8" lower_limit="5.19" upper_limit="6.30"/>
                    <measurement group_id="O4" value="18.2" lower_limit="5.19" upper_limit="6.74"/>
                    <measurement group_id="O5" value="4.5" lower_limit="4.04" upper_limit="4.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707[B44]1:8; N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.4" lower_limit="7.40" upper_limit="9.60"/>
                    <measurement group_id="O2" value="61.9" lower_limit="13.51" upper_limit="17.87"/>
                    <measurement group_id="O3" value="12.6" lower_limit="4.78" upper_limit="5.68"/>
                    <measurement group_id="O4" value="70.1" lower_limit="16.03" upper_limit="22.78"/>
                    <measurement group_id="O5" value="23.8" lower_limit="5.45" upper_limit="8.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707[B44]1:8; N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.5" lower_limit="35.16" upper_limit="46.11"/>
                    <measurement group_id="O2" value="86.1" lower_limit="30.63" upper_limit="39.91"/>
                    <measurement group_id="O3" value="77.5" lower_limit="19.60" upper_limit="25.72"/>
                    <measurement group_id="O4" value="23.9" lower_limit="5.52" upper_limit="7.07"/>
                    <measurement group_id="O5" value="73.0" lower_limit="14.12" upper_limit="22.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Serum Bactericidal Assay Using Human Complement (hSBA) Titer &gt;= Prespecified Titer Level</title>
        <time_frame>Before Injection 1, 1 Month after Injection 2, 3, 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
          <group group_id="O3">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
            <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Serum Bactericidal Assay Using Human Complement (hSBA) Titer &gt;= Prespecified Titer Level</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="365"/>
                <count group_id="O2" value="360"/>
                <count group_id="O3" value="371"/>
                <count group_id="O4" value="241"/>
                <count group_id="O5" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Before Inj1:PMB80[A22] 1:4; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.9" lower_limit="6.41" upper_limit="7.87"/>
                    <measurement group_id="O2" value="23.9" lower_limit="5.72" upper_limit="6.95"/>
                    <measurement group_id="O3" value="26.4" lower_limit="5.84" upper_limit="7.02"/>
                    <measurement group_id="O4" value="23.8" lower_limit="5.66" upper_limit="7.22"/>
                    <measurement group_id="O5" value="25.9" lower_limit="5.59" upper_limit="8.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB80[A22] 1:16; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.2" lower_limit="15.28" upper_limit="20.47"/>
                    <measurement group_id="O2" value="20.5" lower_limit="29.34" upper_limit="36.92"/>
                    <measurement group_id="O3" value="22.8" lower_limit="9.09" upper_limit="11.68"/>
                    <measurement group_id="O4" value="22.1" lower_limit="32.23" upper_limit="42.76"/>
                    <measurement group_id="O5" value="24.1" lower_limit="12.15" upper_limit="21.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB80[A22] 1:32; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.3" lower_limit="48.87" upper_limit="62.07"/>
                    <measurement group_id="O2" value="14.5" lower_limit="50.91" upper_limit="62.27"/>
                    <measurement group_id="O3" value="13.5" lower_limit="43.45" upper_limit="53.86"/>
                    <measurement group_id="O4" value="13.2" lower_limit="12.08" upper_limit="16.73"/>
                    <measurement group_id="O5" value="15.7" lower_limit="32.31" upper_limit="48.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB80[A22] 1:64; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" lower_limit="6.06" upper_limit="7.64"/>
                    <measurement group_id="O2" value="6.5" lower_limit="5.54" upper_limit="6.77"/>
                    <measurement group_id="O3" value="4.7" lower_limit="6.00" upper_limit="7.48"/>
                    <measurement group_id="O4" value="6.8" lower_limit="5.54" upper_limit="7.15"/>
                    <measurement group_id="O5" value="7.4" lower_limit="5.10" upper_limit="7.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB80[A22]1:128; N=356,352,364,235,108</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" lower_limit="68.54" upper_limit="87.12"/>
                    <measurement group_id="O2" value="2.3" lower_limit="14.56" upper_limit="19.96"/>
                    <measurement group_id="O3" value="1.6" lower_limit="15.81" upper_limit="21.63"/>
                    <measurement group_id="O4" value="2.6" lower_limit="14.45" upper_limit="21.58"/>
                    <measurement group_id="O5" value="1.9" lower_limit="5.52" upper_limit="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22] 1:4; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.9" lower_limit="41.96" upper_limit="55.50"/>
                    <measurement group_id="O2" value="47.8" lower_limit="84.64" upper_limit="105.68"/>
                    <measurement group_id="O3" value="51.3" lower_limit="12.89" upper_limit="17.74"/>
                    <measurement group_id="O4" value="52.2" lower_limit="93.16" upper_limit="118.05"/>
                    <measurement group_id="O5" value="29.1" lower_limit="19.48" upper_limit="36.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22] 1:16; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.5" lower_limit="4.93" upper_limit="5.75"/>
                    <measurement group_id="O2" value="45.8" lower_limit="4.77" upper_limit="5.52"/>
                    <measurement group_id="O3" value="50.7" lower_limit="4.70" upper_limit="5.38"/>
                    <measurement group_id="O4" value="51.8" lower_limit="4.49" upper_limit="5.24"/>
                    <measurement group_id="O5" value="27.3" lower_limit="4.51" upper_limit="5.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22] 1:32; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.4" lower_limit="12.15" upper_limit="15.57"/>
                    <measurement group_id="O2" value="28.7" lower_limit="7.38" upper_limit="9.21"/>
                    <measurement group_id="O3" value="34.5" lower_limit="8.20" upper_limit="10.28"/>
                    <measurement group_id="O4" value="37.9" lower_limit="8.39" upper_limit="11.35"/>
                    <measurement group_id="O5" value="18.2" lower_limit="4.70" upper_limit="6.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22] 1:64; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.8" lower_limit="9.61" upper_limit="12.50"/>
                    <measurement group_id="O2" value="14.5" lower_limit="13.20" upper_limit="16.73"/>
                    <measurement group_id="O3" value="14.5" lower_limit="6.75" upper_limit="8.35"/>
                    <measurement group_id="O4" value="19.6" lower_limit="15.24" upper_limit="20.49"/>
                    <measurement group_id="O5" value="6.4" lower_limit="10.01" upper_limit="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB80[A22]1:128; N=351,345,351,224,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" lower_limit="25.88" upper_limit="32.66"/>
                    <measurement group_id="O2" value="5.2" lower_limit="23.03" upper_limit="28.45"/>
                    <measurement group_id="O3" value="5.7" lower_limit="18.38" upper_limit="23.18"/>
                    <measurement group_id="O4" value="8.5" lower_limit="7.01" upper_limit="9.24"/>
                    <measurement group_id="O5" value="0.9" lower_limit="12.01" upper_limit="18.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22] 1:4; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.6" lower_limit="4.18" upper_limit="4.54"/>
                    <measurement group_id="O2" value="88.7" lower_limit="4.24" upper_limit="4.67"/>
                    <measurement group_id="O3" value="45.6" lower_limit="4.26" upper_limit="4.70"/>
                    <measurement group_id="O4" value="90.8" lower_limit="4.28" upper_limit="4.90"/>
                    <measurement group_id="O5" value="55.9" lower_limit="4.04" upper_limit="4.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22]1:16; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.3" lower_limit="7.40" upper_limit="9.60"/>
                    <measurement group_id="O2" value="88.1" lower_limit="13.51" upper_limit="17.87"/>
                    <measurement group_id="O3" value="42.4" lower_limit="4.78" upper_limit="5.68"/>
                    <measurement group_id="O4" value="90.8" lower_limit="16.03" upper_limit="22.78"/>
                    <measurement group_id="O5" value="55.9" lower_limit="5.45" upper_limit="8.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22]1:32; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.3" lower_limit="35.16" upper_limit="46.11"/>
                    <measurement group_id="O2" value="69.5" lower_limit="30.63" upper_limit="39.91"/>
                    <measurement group_id="O3" value="30.6" lower_limit="19.60" upper_limit="25.72"/>
                    <measurement group_id="O4" value="70.6" lower_limit="5.52" upper_limit="7.07"/>
                    <measurement group_id="O5" value="45.1" lower_limit="14.12" upper_limit="22.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22]1:64; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.3"/>
                    <measurement group_id="O2" value="35.8"/>
                    <measurement group_id="O3" value="12.4"/>
                    <measurement group_id="O4" value="39.1"/>
                    <measurement group_id="O5" value="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB80[A22]1:128; N=332,344,340,238,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7"/>
                    <measurement group_id="O2" value="14.8"/>
                    <measurement group_id="O3" value="4.4"/>
                    <measurement group_id="O4" value="19.7"/>
                    <measurement group_id="O5" value="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22] 1:4; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9"/>
                    <measurement group_id="O2" value="95.0"/>
                    <measurement group_id="O3" value="94.0"/>
                    <measurement group_id="O4" value="58.1"/>
                    <measurement group_id="O5" value="91.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22] 1:16; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.4"/>
                    <measurement group_id="O2" value="95.0"/>
                    <measurement group_id="O3" value="93.2"/>
                    <measurement group_id="O4" value="56.0"/>
                    <measurement group_id="O5" value="91.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22] 1:32; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.2"/>
                    <measurement group_id="O2" value="86.6"/>
                    <measurement group_id="O3" value="81.8"/>
                    <measurement group_id="O4" value="38.0"/>
                    <measurement group_id="O5" value="74.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22] 1:64; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9"/>
                    <measurement group_id="O2" value="63.9"/>
                    <measurement group_id="O3" value="53.9"/>
                    <measurement group_id="O4" value="19.2"/>
                    <measurement group_id="O5" value="42.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB80[A22]1:128; N=360,357,369,234,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7"/>
                    <measurement group_id="O2" value="32.5"/>
                    <measurement group_id="O3" value="25.7"/>
                    <measurement group_id="O4" value="8.5"/>
                    <measurement group_id="O5" value="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2001[A56] 1:4;N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.1"/>
                    <measurement group_id="O2" value="22.1"/>
                    <measurement group_id="O3" value="25.1"/>
                    <measurement group_id="O4" value="25.5"/>
                    <measurement group_id="O5" value="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2001[A56]1:16;N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0"/>
                    <measurement group_id="O2" value="18.1"/>
                    <measurement group_id="O3" value="20.3"/>
                    <measurement group_id="O4" value="19.0"/>
                    <measurement group_id="O5" value="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2001[A56]1:32;N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.0"/>
                    <measurement group_id="O2" value="14.1"/>
                    <measurement group_id="O3" value="17.2"/>
                    <measurement group_id="O4" value="15.6"/>
                    <measurement group_id="O5" value="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2001[A56]1:64;N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7"/>
                    <measurement group_id="O2" value="7.5"/>
                    <measurement group_id="O3" value="10.7"/>
                    <measurement group_id="O4" value="8.7"/>
                    <measurement group_id="O5" value="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1: PMB2001 1:128;N=350,348,355,231,107</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3"/>
                    <measurement group_id="O2" value="2.3"/>
                    <measurement group_id="O3" value="3.7"/>
                    <measurement group_id="O4" value="2.6"/>
                    <measurement group_id="O5" value="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001[A56] 1:4;N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.6"/>
                    <measurement group_id="O2" value="61.4"/>
                    <measurement group_id="O3" value="63.3"/>
                    <measurement group_id="O4" value="60.1"/>
                    <measurement group_id="O5" value="25.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001[A56]1:16;N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.3"/>
                    <measurement group_id="O2" value="55.0"/>
                    <measurement group_id="O3" value="57.9"/>
                    <measurement group_id="O4" value="55.5"/>
                    <measurement group_id="O5" value="21.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001[A56]1:32;N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8"/>
                    <measurement group_id="O2" value="48.0"/>
                    <measurement group_id="O3" value="50.1"/>
                    <measurement group_id="O4" value="47.2"/>
                    <measurement group_id="O5" value="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001[A56]1:64;N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.8"/>
                    <measurement group_id="O2" value="27.4"/>
                    <measurement group_id="O3" value="31.0"/>
                    <measurement group_id="O4" value="29.8"/>
                    <measurement group_id="O5" value="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2001 1:128;N=353,329,335,218,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.1"/>
                    <measurement group_id="O2" value="14.3"/>
                    <measurement group_id="O3" value="14.9"/>
                    <measurement group_id="O4" value="15.6"/>
                    <measurement group_id="O5" value="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2001[A56] 1:4;N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.5"/>
                    <measurement group_id="O2" value="98.5"/>
                    <measurement group_id="O3" value="54.4"/>
                    <measurement group_id="O4" value="100.0"/>
                    <measurement group_id="O5" value="72.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2001[A56]1:16;N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8"/>
                    <measurement group_id="O2" value="97.9"/>
                    <measurement group_id="O3" value="50.0"/>
                    <measurement group_id="O4" value="99.2"/>
                    <measurement group_id="O5" value="65.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2001[A56]1:32;N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.9"/>
                    <measurement group_id="O2" value="94.1"/>
                    <measurement group_id="O3" value="43.8"/>
                    <measurement group_id="O4" value="95.0"/>
                    <measurement group_id="O5" value="55.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2001[A56]1:64;N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.9"/>
                    <measurement group_id="O2" value="79.1"/>
                    <measurement group_id="O3" value="28.4"/>
                    <measurement group_id="O4" value="81.7"/>
                    <measurement group_id="O5" value="39.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2001 1:128;N=329,339,320,240,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.7"/>
                    <measurement group_id="O2" value="50.4"/>
                    <measurement group_id="O3" value="13.1"/>
                    <measurement group_id="O4" value="57.1"/>
                    <measurement group_id="O5" value="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001[A56] 1:4;N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.7"/>
                    <measurement group_id="O2" value="99.2"/>
                    <measurement group_id="O3" value="98.9"/>
                    <measurement group_id="O4" value="79.8"/>
                    <measurement group_id="O5" value="99.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001[A56]1:16;N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.2"/>
                    <measurement group_id="O2" value="98.9"/>
                    <measurement group_id="O3" value="98.4"/>
                    <measurement group_id="O4" value="74.6"/>
                    <measurement group_id="O5" value="99.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001[A56]1:32;N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.3"/>
                    <measurement group_id="O2" value="96.1"/>
                    <measurement group_id="O3" value="94.6"/>
                    <measurement group_id="O4" value="59.6"/>
                    <measurement group_id="O5" value="92.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001[A56]1:64;N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8"/>
                    <measurement group_id="O2" value="91.1"/>
                    <measurement group_id="O3" value="83.8"/>
                    <measurement group_id="O4" value="34.2"/>
                    <measurement group_id="O5" value="85.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2001 1:128;N=362,359,370,228,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.4"/>
                    <measurement group_id="O2" value="73.5"/>
                    <measurement group_id="O3" value="65.9"/>
                    <measurement group_id="O4" value="15.8"/>
                    <measurement group_id="O5" value="60.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948[B24]1:4;N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5"/>
                    <measurement group_id="O2" value="15.4"/>
                    <measurement group_id="O3" value="14.4"/>
                    <measurement group_id="O4" value="13.3"/>
                    <measurement group_id="O5" value="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948[B24]1:16;N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.7"/>
                    <measurement group_id="O2" value="11.5"/>
                    <measurement group_id="O3" value="10.8"/>
                    <measurement group_id="O4" value="8.7"/>
                    <measurement group_id="O5" value="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948[B24]1:32;N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2"/>
                    <measurement group_id="O2" value="6.2"/>
                    <measurement group_id="O3" value="6.0"/>
                    <measurement group_id="O4" value="5.0"/>
                    <measurement group_id="O5" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948[B24]1:64;N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8"/>
                    <measurement group_id="O2" value="3.1"/>
                    <measurement group_id="O3" value="2.2"/>
                    <measurement group_id="O4" value="2.1"/>
                    <measurement group_id="O5" value="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2948 1:128;N=362,356,369,241,112</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                    <measurement group_id="O2" value="0.8"/>
                    <measurement group_id="O3" value="0.5"/>
                    <measurement group_id="O4" value="0.8"/>
                    <measurement group_id="O5" value="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948[B24]1:4;N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.3"/>
                    <measurement group_id="O2" value="42.3"/>
                    <measurement group_id="O3" value="45.7"/>
                    <measurement group_id="O4" value="47.1"/>
                    <measurement group_id="O5" value="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948[B24]1:16;N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.6"/>
                    <measurement group_id="O2" value="32.8"/>
                    <measurement group_id="O3" value="39.5"/>
                    <measurement group_id="O4" value="40.4"/>
                    <measurement group_id="O5" value="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948[B24]1:32;N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9"/>
                    <measurement group_id="O2" value="18.6"/>
                    <measurement group_id="O3" value="23.3"/>
                    <measurement group_id="O4" value="24.7"/>
                    <measurement group_id="O5" value="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948[B24]1:64;N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0"/>
                    <measurement group_id="O2" value="9.0"/>
                    <measurement group_id="O3" value="8.8"/>
                    <measurement group_id="O4" value="11.7"/>
                    <measurement group_id="O5" value="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2948 1:128;N=344,345,352,223,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1"/>
                    <measurement group_id="O2" value="3.5"/>
                    <measurement group_id="O3" value="2.6"/>
                    <measurement group_id="O4" value="4.5"/>
                    <measurement group_id="O5" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948[B24]1:4;N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.1"/>
                    <measurement group_id="O2" value="72.1"/>
                    <measurement group_id="O3" value="37.6"/>
                    <measurement group_id="O4" value="75.5"/>
                    <measurement group_id="O5" value="57.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948[B24]1:16;N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.1"/>
                    <measurement group_id="O2" value="63.5"/>
                    <measurement group_id="O3" value="29.7"/>
                    <measurement group_id="O4" value="67.1"/>
                    <measurement group_id="O5" value="52.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948[B24]1:32;N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.8"/>
                    <measurement group_id="O2" value="32.0"/>
                    <measurement group_id="O3" value="15.9"/>
                    <measurement group_id="O4" value="43.5"/>
                    <measurement group_id="O5" value="32.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948[B24]1:64;N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5"/>
                    <measurement group_id="O2" value="13.6"/>
                    <measurement group_id="O3" value="5.0"/>
                    <measurement group_id="O4" value="19.4"/>
                    <measurement group_id="O5" value="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2948 1:128;N=328,337,340,237,102</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7"/>
                    <measurement group_id="O2" value="6.5"/>
                    <measurement group_id="O3" value="2.6"/>
                    <measurement group_id="O4" value="8.4"/>
                    <measurement group_id="O5" value="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948[B24]1:4;N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.1"/>
                    <measurement group_id="O2" value="90.1"/>
                    <measurement group_id="O3" value="83.0"/>
                    <measurement group_id="O4" value="38.2"/>
                    <measurement group_id="O5" value="70.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948[B24]1:16;N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.8"/>
                    <measurement group_id="O2" value="83.6"/>
                    <measurement group_id="O3" value="73.8"/>
                    <measurement group_id="O4" value="32.9"/>
                    <measurement group_id="O5" value="64.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948[B24]1:32;N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.7"/>
                    <measurement group_id="O2" value="56.2"/>
                    <measurement group_id="O3" value="47.1"/>
                    <measurement group_id="O4" value="18.0"/>
                    <measurement group_id="O5" value="33.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948[B24]1:64;N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3"/>
                    <measurement group_id="O2" value="26.6"/>
                    <measurement group_id="O3" value="22.6"/>
                    <measurement group_id="O4" value="10.5"/>
                    <measurement group_id="O5" value="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2948 1:128;N=354,354,359,228,110</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.0"/>
                    <measurement group_id="O2" value="10.5"/>
                    <measurement group_id="O3" value="7.2"/>
                    <measurement group_id="O4" value="3.1"/>
                    <measurement group_id="O5" value="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707[B44]1:4;N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7"/>
                    <measurement group_id="O2" value="7.8"/>
                    <measurement group_id="O3" value="7.8"/>
                    <measurement group_id="O4" value="8.3"/>
                    <measurement group_id="O5" value="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707[B44]1:16;N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6"/>
                    <measurement group_id="O2" value="5.0"/>
                    <measurement group_id="O3" value="4.9"/>
                    <measurement group_id="O4" value="6.6"/>
                    <measurement group_id="O5" value="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707[B44]1:32;N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0"/>
                    <measurement group_id="O2" value="2.5"/>
                    <measurement group_id="O3" value="3.5"/>
                    <measurement group_id="O4" value="2.9"/>
                    <measurement group_id="O5" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707[B44]1:64;N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6"/>
                    <measurement group_id="O2" value="1.4"/>
                    <measurement group_id="O3" value="1.4"/>
                    <measurement group_id="O4" value="1.2"/>
                    <measurement group_id="O5" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Before Inj1:PMB2707 1:128;N=363,357,370,241,113</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.3"/>
                    <measurement group_id="O3" value="0.3"/>
                    <measurement group_id="O4" value="0.8"/>
                    <measurement group_id="O5" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707[B44]1:4;N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.5"/>
                    <measurement group_id="O2" value="17.7"/>
                    <measurement group_id="O3" value="20.6"/>
                    <measurement group_id="O4" value="20.4"/>
                    <measurement group_id="O5" value="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707[B44]1:16;N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.2"/>
                    <measurement group_id="O2" value="13.6"/>
                    <measurement group_id="O3" value="14.0"/>
                    <measurement group_id="O4" value="14.2"/>
                    <measurement group_id="O5" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707[B44]1:32;N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.0"/>
                    <measurement group_id="O2" value="9.9"/>
                    <measurement group_id="O3" value="8.3"/>
                    <measurement group_id="O4" value="9.8"/>
                    <measurement group_id="O5" value="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707[B44]1:64;N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8"/>
                    <measurement group_id="O2" value="4.1"/>
                    <measurement group_id="O3" value="5.2"/>
                    <measurement group_id="O4" value="6.2"/>
                    <measurement group_id="O5" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj2:PMB2707 1:128;N=341,345,349,225,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0"/>
                    <measurement group_id="O2" value="1.7"/>
                    <measurement group_id="O3" value="3.7"/>
                    <measurement group_id="O4" value="4.0"/>
                    <measurement group_id="O5" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707[B44]1:4;N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.0"/>
                    <measurement group_id="O2" value="65.9"/>
                    <measurement group_id="O3" value="15.5"/>
                    <measurement group_id="O4" value="73.5"/>
                    <measurement group_id="O5" value="28.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707[B44]1:16;N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.3"/>
                    <measurement group_id="O2" value="58.6"/>
                    <measurement group_id="O3" value="10.9"/>
                    <measurement group_id="O4" value="64.5"/>
                    <measurement group_id="O5" value="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707[B44]1:32;N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.6"/>
                    <measurement group_id="O2" value="39.0"/>
                    <measurement group_id="O3" value="5.9"/>
                    <measurement group_id="O4" value="42.3"/>
                    <measurement group_id="O5" value="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707[B44]1:64;N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4"/>
                    <measurement group_id="O2" value="22.7"/>
                    <measurement group_id="O3" value="3.8"/>
                    <measurement group_id="O4" value="24.4"/>
                    <measurement group_id="O5" value="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj3:PMB2707 1:128;N=333,331,341,234,105</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3"/>
                    <measurement group_id="O2" value="7.9"/>
                    <measurement group_id="O3" value="2.6"/>
                    <measurement group_id="O4" value="14.1"/>
                    <measurement group_id="O5" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707[B44]1:4;N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.3"/>
                    <measurement group_id="O2" value="87.8"/>
                    <measurement group_id="O3" value="78.9"/>
                    <measurement group_id="O4" value="26.1"/>
                    <measurement group_id="O5" value="73.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707[B44]1:16;N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.8"/>
                    <measurement group_id="O2" value="83.8"/>
                    <measurement group_id="O3" value="70.8"/>
                    <measurement group_id="O4" value="19.1"/>
                    <measurement group_id="O5" value="66.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707[B44]1:32;N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.5"/>
                    <measurement group_id="O2" value="65.3"/>
                    <measurement group_id="O3" value="49.2"/>
                    <measurement group_id="O4" value="10.0"/>
                    <measurement group_id="O5" value="39.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707[B44]1:64;N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.6"/>
                    <measurement group_id="O2" value="42.3"/>
                    <measurement group_id="O3" value="27.8"/>
                    <measurement group_id="O4" value="5.2"/>
                    <measurement group_id="O5" value="20.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1M aft Inj4:PMB2707 1:128;N=356,352,356,230,111</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.5"/>
                    <measurement group_id="O2" value="22.7"/>
                    <measurement group_id="O3" value="13.8"/>
                    <measurement group_id="O4" value="3.9"/>
                    <measurement group_id="O5" value="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Participants Achieving At Least 4-fold Increase in hSBA Titer</title>
        <time_frame>1 month after Injection 2, 3, 4</time_frame>
        <population>Results were not reported because a decision was made a priori that, although the fold rise outcome measure will still be performed, it will not be performed as a secondary outcome measure. Therefore it was moved from a secondary outcome measure in an earlier protocol version to an exploratory outcome measure in the final protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
          </group>
          <group group_id="O2">
            <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
          </group>
          <group group_id="O3">
            <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
            <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
            <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving At Least 4-fold Increase in hSBA Titer</title>
          <population>Results were not reported because a decision was made a priori that, although the fold rise outcome measure will still be performed, it will not be performed as a secondary outcome measure. Therefore it was moved from a secondary outcome measure in an earlier protocol version to an exploratory outcome measure in the final protocol.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>AE reported from Injection 1 to 1 month after last administration of investigational product (bivalent rLP2086/saline). SAE reported from Injection 1 to 6 months after last of investigational product (bivalent rLP2086/saline)</time_frame>
      <desc>Some participants randomized to receive vaccination as per Groups 1, 2 or 4 schedules actually received vaccination as per Group 3 schedule. One participant was not randomized but received Saline at Injection 1 and was included in Group 5. Participants have been presented as per actual administration schedule received.</desc>
      <group_list>
        <group group_id="E1">
          <title>Group 1:rLP2086(0-,1-,6- Month)+Saline(2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 1-, 6- month and 0.9% normal saline on a 2- month schedule.</description>
        </group>
        <group group_id="E2">
          <title>Group 2:rLP2086(0-,2-,6- Month)+Saline(1- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2-, 6- month and 0.9% normal saline on a 1- month schedule.</description>
        </group>
        <group group_id="E3">
          <title>Group 3: rLP2086(0-,6- Month)+Saline(1-,2- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 6- month and 0.9% normal saline on a 1-, 2- month schedule.</description>
        </group>
        <group group_id="E4">
          <title>Group 4: rLP2086(0-,2- Month)+Saline(1-,6- Month)</title>
          <description>Randomized to receive rLP2086 on a 0-, 2- month and 0.9% normal saline on a 1-, 6- month schedule.</description>
        </group>
        <group group_id="E5">
          <title>Group 5: rLP2086(2-,6- Month)+ Saline(0-,1- Month)</title>
          <description>Randomized to receive rLP2086 on a 2-, 6- month and 0.9% normal saline on a 0-, 1- month schedule.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 15.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Infectious mononucleosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Tonsillitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Foreign body</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Near drowning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Sympathetic posterior cervical syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>MedDRA 15.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="115" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="114" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="72" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="43" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="21" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="8" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="451"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="277"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="144"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

